Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
Clinical trial NCT01573247 · TERMINATED
Trial details
- NCT number
- NCT01573247
- Sponsor
- Akinion Pharmaceuticals AB
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.